Table 3.
Adjusted odd ratio (OR) and 95% confidence interval (CI) of hyperuricemia (serum uric acid ≥ 7.0 mg/dL and/or medication for hyperuricemia) for MTHFR C677T among those with ABCG2 126QQ and SLC22A12 258WW
| Genotype | OR | 95% CI | ||
|---|---|---|---|---|
| All subjects | (n = 4,539) | |||
| MTHFR C677T | CC | 1 | (Reference) | |
| CT | 1.00 | 0.89–1.24 | ||
| TT | 0.98 | 0.84–1.32 | ||
| Males | (n = 3,086) | |||
| MTHFR C677T | CC | 1 | (Reference) | |
| CT | 1.00 | 0.88–1.25 | ||
| TT | 0.97 | 0.83–1.35 | ||
| Females | (n= 1,453) | |||
| MTHFR C677T | CC | 1 | (Reference) | |
| CT | 1.02 | 0.32–2.07 | ||
| TT | 0.69 | 0.27–4.08 |
Adjusted for (sex), age, BMI and creatinine